Bharat Immunological & Biologicals Corporation Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Bharat Immunological & Biologicals Corporation Ltd. on BSE

Load latest

Bharat Immunological & Biologicals Corporation Ltd.

04 May 2018

20.58

1.28%

Result

Limited Review Report By Practicing Chartered Accountants On Un Audited Quarterly Financial Results For The Quarter …

BSE India

Sir In pursuance of Regulation 33(3) (C ) of the LODR with Stock Exchange, please find enclosed the Limited Review Report along with the financial results for the Quarter ended 31st March 2018. It is requested to kindly take the above on record please.

pdf

Bharat Immunological & Biologicals Corporation Ltd.

25 Apr 2018

20.58

1.28%

Result

Submission Of Unaudited Quarterly Fiancial Results For The Quarter Ended March 2018 As Compliance Of LODR …

BSE India

Sir In pursuance of the LODR with Stock Exchange, please find enclosed the Unaudited quarterly financial results for the quarter ended March 2018 duly approved by the Board of the Company in its Meeting on 24.04.2018. This submission of UAFR will succeeded by XBRL filing as per the requirement of Exchange. Submitted please.

pdf

Bharat Immunological & Biologicals Corporation Ltd.

25 Apr 2018

20.58

1.28%

Annual Report

Annual report for Bharat Immunological & Biologicals Corporation Ltd. for FY-2018

pdf

Bharat Immunological & Biologicals Corporation Ltd.

13 Apr 2018

20.58

1.28%

Board Meeting

Intimation Of Date Of Board Meeting On 24.04.2018 Under Regulation 29 Of SEBI'S LODR

BSE India

Pursuant to the Regulation 29 and other applicable Regulation(s) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, it is informed that a meeting of the Board of Directors of the Company is scheduled to be held on Tuesday, 24th April 2018, to approve and take on record the Un-audited Quarterly Financial Results of the Company for the quarter ended 31st March 2018.

pdf

Bharat Immunological & Biologicals Corporation Ltd.

10 Apr 2018

20.58

1.28%

Company Update

Shareholding for the Period Ended March 31, 2018

BSE India

Bharat Immunologicals & Biologicals Corporation Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2018. For more details, kindly Click here

Bharat Immunological & Biologicals Corporation Ltd.

22 Jan 2018

20.58

1.28%

Result

Un Audited Quarterly Financial Results For The Quarter Ended December 2017 Of 201718

BSE India

Sir, In pursuance of Regulation 33(3) (C ) of the LODR with Stock Exchange, please find enclosed the Limited Review Report along with the financial results for the Quarter ended 31st December 2017. It is requested to kindly take the above on record please. Thanking you,

pdf

Bharat Immunological & Biologicals Corporation Ltd.

17 Jan 2018

20.58

1.28%

Company Update

Shareholding for the Period Ended December 31, 2017

BSE India

Bharat Immunologicals & Biologicals Corporation Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2017. For more details, kindly Click here

Bharat Immunological & Biologicals Corporation Ltd.

15 Jan 2018

20.58

1.28%

Result

Updates

BSE India

In pursuance of the LODR with Stock Exchange, please find enclosed the Unaudited quarterly financial results for the quarter ended December 2017 duly approved by the Board of the Company in its Meeting on 15.01.2018. This submission of UAFR will succeeded by XBRL filing as per the requirement of Exchange. Submitted please.

pdf

Bharat Immunological & Biologicals Corporation Ltd.

26 Dec 2017

20.58

1.28%

Board Meeting

Intimation Of Date Of Board Meeting On 15.01.2018, Under Regulation 29 Of SEBI'S LODR.

BSE India

Pursuant to the Regulation 29 and other applicable Regulation(s) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, it is informed that a meeting of the Board of Directors of the Company is scheduled to be held on Monday, 15th January 2018, to approve and take on record the Un-audited Quarterly Financial Results of the Company for the quarter ended 31st December 2017.

pdf

Bharat Immunological & Biologicals Corporation Ltd.

03 Nov 2017

20.58

1.28%

Company Update

Submission Of Certificate From Practicising Company Secretary Under Regulation 40 Of SEBI (LODR) Regulations 2015 For …

BSE India

Sir, In pursuance of Regulation 40 of the LODR with Stock Exchange, please find attached the Certificate from Practicising Company Secretary for the half year ended 30th September 2017. It is requested to take the above on record.

pdf

No results found

Is Bharat Immunological & Biologicals Corporation Ltd. worth buying?

135 Votes:

Buy 69.63%

Sell 14.81%

Hold 15.56%

42.64% Fall from 52W High

High vol. this week

Bharat Immunological & Biologicals Corporation Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Bharat Immunological & Biologicals Corporation Ltd. on BSE